Name:   MartiniMan - Subject:   Peer reviewed study on hydroxychloroquine Date:   7/4/2020 10:12:59 AM

Bad news for TDS sufferers but it actually works.  cnnBS found the results "surprising" because science actually proved that Trump was right all along.  Of course many other countries have been using it successfully for months albeit they have been giving it to patients that are not on death's doorstep like the previous studies in the U.S.

A surprising new study found that the controversial antimalarial drug hydroxychloroquine helped patients better survive in the hospital.

A team at Henry Ford Health System in Southeast Michigan said Thursday its study of 2,541 hospitalized patients found that those given hydroxychloroquine were much less likely to die.

Dr. Marcus Zervos, division head of infectious disease for Henry Ford Health System, said 26% of those not given hydroxychloroquine died, compared to 13% of those who got the drug. The team looked back at everyone treated in the hospital system since the first patient in March.

"Overall crude mortality rates were 18.1% in the entire cohort, 13.5% in the hydroxychloroquine alone group, 20.1% among those receiving hydroxychloroquine plus azithromycin, 22.4% among the azithromycin alone group, and 26.4% for neither drug," the team wrote in a report published in the International Journal of Infectious Diseases.

[…]

The Henry Ford team also monitored patients carefully for heart problems, he said.

"The combination of hydroxychloroquine plus azithromycin was reserved for selected patients with severe COVID-19 and with minimal cardiac risk factors," the team wrote.

The Henry Ford team said they believe their findings show hydroxychloroquine could be potentially useful as a treatment for coronavirus.

"It's important to note that in the right settings, this potentially could be a lifesaver for patients," Dr. Steven Kalkanis, CEO of the Henry Ford Medical Group, said at the news conference.